More Than 200 Companies Advance Trial Management with Veeva CTMS

PR Newswire01-29

Biopharmas use leading CTMS for improved trial efficiency and collaboration PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2507268785?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-29 20:03","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2507268785","market":"us","top_or_hot":-1,"title":"More Than 200 Companies Advance Trial Management with Veeva CTMS","media":"PR Newswire","content":"<div>\n<p>Biopharmas use leading CTMS for improved trial efficiency and collaboration\nPLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – ...</p>\n\n<a href=\"https://finance.yahoo.com/news/more-200-companies-advance-trial-120300562.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>More Than 200 Companies Advance Trial Management with Veeva CTMS</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMore Than 200 Companies Advance Trial Management with Veeva CTMS\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-29 20:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/more-200-companies-advance-trial-120300562.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biopharmas use leading CTMS for improved trial efficiency and collaboration\nPLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – ...</p>\n\n<a href=\"https://finance.yahoo.com/news/more-200-companies-advance-trial-120300562.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0058720904.USD","symbol_name":"联博国际健康护理基金A","start_time":0,"source_url":"https://finance.yahoo.com/news/more-200-companies-advance-trial-120300562.html","article_id":"2507268785","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/more-200-companies-advance-trial-120300562.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2507268785","pubTimestamp":1738152180,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Biopharmas use leading CTMS for improved trial efficiency and collaboration. PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems  today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute faster, more efficient trials. As study complexity and data volumes increase, biopharmas and CROs are centralizing data and documents with Veeva CTMS to streamline processes and drive stakeholder collaboration.\"Veeva CTMS is the central hub of our trials, allowing study metrics and documents to flow seamlessly across our ecosystem,\" said Bonne Adams, vice president of operations at Inhibrx. \"Using clinical applications on a connected platform saves time and effort for our lean team and improves how we work with CRO partners.\". About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging f","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0058720904.USD":"联博国际健康护理基金A","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","VEEV":"Veeva Systems Inc.","BK4167":"医疗保健技术","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","BK4504":"桥水持仓","BK4588":"碎股","BK4528":"SaaS概念","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc"},"translate_title":"200多家公司利用Veeva CTMS推进试验管理","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VEEV":1},"content_text":"Biopharmas use leading CTMS for improved trial efficiency and collaboration\nPLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute faster, more efficient trials. As study complexity and data volumes increase, biopharmas and CROs are centralizing data and documents with Veeva CTMS to streamline processes and drive stakeholder collaboration.\n\n  \n\n\"Veeva CTMS is the central hub of our trials, allowing study metrics and documents to flow seamlessly across our ecosystem,\" said Bonne Adams, vice president of operations at Inhibrx. \"Using clinical applications on a connected platform saves time and effort for our lean team and improves how we work with CRO partners.\"\nWhether biopharmas insource or outsource trials, clinical teams can use Veeva CTMS to proactively manage studies and quickly identify and address issues. With a flexible and scalable system, companies can accelerate trial execution and deliver high-quality data while maintaining compliance with global regulations like ICH E6(R2) and (R3).\nTo help biopharmas adapt to trial operating model changes and keep up with evolving regulations, Veeva continues to deliver clinical innovations. New Veeva CTMS advancements include:\n\nCTMS transfer automates daily data transfers from CROs to sponsors for greater visibility\nOversight issue tracking and management for faster resolution\nEnhancements to manage insourced, outsourced, and complex trials for speed and agility\n\n\"Modern clinical trial management systems should scale easily and support both insourced and outsourced operating models,\" said Henry Galio, vice president of Veeva CTMS strategy. \"To provide this flexibility, we're delivering new capabilities for Veeva CTMS through our three product releases per year, continuously advancing to help the industry work better together and accelerate execution.\"\nWith the increased adoption of Veeva CTMS, more companies are simplifying trial operations and maintaining compliance regardless of operating model. Veeva CTMS is part of Veeva Clinical Platform, the most complete and highest-quality platform for faster and more efficient trials. Learn more about Veeva CTMS at SCOPE 2025 booth 916, Feb. 3-6 in Orlando.\nAdditional InformationFor more on Veeva CTMS, visit: veeva.com/CTMS Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems\nAbout Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.\nVeeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.\nContact:\nDeivis MercadoVeeva Systems925-226-8821deivis.mercado@veeva.com\n View original content to download multimedia:https://www.prnewswire.com/news-releases/more-than-200-companies-advance-trial-management-with-veeva-ctms-302362835.html\nSOURCE Veeva Systems","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2507268785"}